Title : A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor.

Pub. Date : 2004 Feb

PMID : 15075667






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The recommended phase II dose of Doxil/docetaxel is 30/60 mg/m(2), q3 weeks, without G-CSF. liposomal doxorubicin colony stimulating factor 3 Homo sapiens